Alzheon Appoints Former IVAX President as Vice Chair of Board
FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological
Read more
Alzheon
Framingham-Based Company’s Scientists Discover Key Driver of Alzheimer’s Disease
FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurodegenerative
Read more
Framingham Company Developing Alzheimer’s Disease Treatments Launches Initial Public Offering
FRAMINGHAM – Alzheon, Inc. announced today, April 2, it has launched the roadshow for the initial public offering of its common stock.
Read more
FDA Fast Tracks Framingham Company’s Drug To Treat Alzheimer’s Disease
FRAMINGHAM – Alzheon, Inc., a clinical stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and
Read more
Framingham-Based Alzheon Appoints Chief Business Officer
FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and
Read more